Payment Models Clause Samples

The Payment Models clause defines the structure and methods by which payments will be made under an agreement. It typically outlines whether payments are to be made as a fixed fee, on a time-and-materials basis, per milestone, or through another specified arrangement, and may detail the timing and conditions for each payment. By clearly establishing how and when payments are calculated and disbursed, this clause ensures both parties have a mutual understanding of financial obligations, reducing the risk of disputes over compensation.
Payment Models. The Customer will be billed either after the respective Billing Period based on its actual usage of IDE Services (post-paid Fees), or the Customer can purchase a Subscription to individual IDE Services, in which case the Fees must be paid up front (prepaid Fees).
View SourceView Similar (6)
Payment Models. Model 1: USD [***] due and payable thirty (30) days after the signing of this Agreement; plus • USD [***] due and payable after the date of FDA notification if the initial NDA results in a final FDA approval of the Product for the indication HTG upon the later of (i) thirty (30) days after such notification, and (ii) the transfer of the Registration for the Product to RELIANT; or • USD [***] due and payable thirty (30) days after the date of FDA notification if the initial NDA results in an Approvable Letter (unless RELIANT shall not have provided a notice to PRONOVA under Section 3.3(a)), plus USD [***] due and payable upon the later of (i) thirty (30) days after the date of FDA notification of final FDA approval of the Product for the indication HTG, and (ii) the transfer of the Registration for the Product to RELIANT. Model 2: USD [***] due and payable thirty (30) days after signing of this Agreement; plus • USD [***] due and payable after the date of FDA notification if the initial NDA results in a final FDA approval of the Product for the indication HTG upon the later of (i) thirty (30) days after such notification, and (ii) the transfer of the Registration for the Product to RELIANT; or • USD [***] due and payable thirty (30) days after the date of FDA notification if the initial NDA results in an Approvable Letter from FDA (unless RELIANT shall not have provided a notice to PRONOVA under Section 3.3(a)), plus USD [***] due and payable upon the later of (i) thirty (30) days after the date of FDA notification of final FDA approval of the Product for the indication HTG, and (ii) the transfer of the Registration for the Product to RELIANT. RELIANT’s obligation to make any of the foregoing “final FDA approval” payments shall be conditioned upon RELIANT’s having received access to validated API to create finished encapsulated Product for sale in the Territory. [***]: Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
View SourceView Similar (4)
Payment Models. The Schedule of Fees payable to GPs, as detailed in a GP Agreement, is known as 'SAMSOF' (South Australian Medical Schedule of Fees). A GP Agreement and the SAMSOF provides the application of the payment model in detail and represents the legally enforceable arrangements agreed at the local level between the relevant RLHN and GP/GP Clinic. Each RLHN will offer a GP/GP clinic, via a GP Agreement, a combination of the following payment models: 1. Off‐site sessional; 2. On‐site sessional; and 3. Fee For Service (FFS) All fees payable under each of these models are exclusively for the provision of services to public patients. No payments shall be made by a RLHN for the provision of private services. All parties engaged under a GP Agreement pursuant to this MOU are bound by compliance requirements (billing, procedural and otherwise) as determined by all applicable Commonwealth and State authorities and legal instruments. Except in specific circumstances, stated in the GP Agreement, where GPs are paid an off‐site or on‐site sessional fee, the GP may not make further claims for payment or bill any other provider or person, including but not limited, to the patient, Medicare, DVA, the LHN, private health insurance and accident and motor insurance, and workers compensation providers. Medical services provided to public patients in public hospitals must comply with the Health Care Act 2008, the National Health Reform Agreement (NHR Agreement), the Health Insurance Act, 1973 and any other legislation applicable for provision of medical services to public patients in public hospitals.
View Source
Payment Models. The payment models available to GPs providing services to the LHNs are expanded with an additional onsite sessional (or hourly rate) payment. The current two payments methods (off-site sessional and FFS) will remain available with significant enhancements. The LHNs will, in consultation with the GP/GP Clinic, determine the payment model to be offered for contracted services based on the LHN’s service delivery requirements.
View Source
Payment Models 
View SourceView Similar (2)

Related to Payment Models

  • Payment Methodology The Grantee shall be reimbursed for actual, reasonable, and necessary costs based upon the Grant Budget, not to exceed the Maximum Liability established in Section 1. Upon progress toward the completion of the Scope, as described in Section A of this Grant Contract, the Grantee shall submit invoices prior to any reimbursement of allowable costs.

  • Payment Methods A. Except as otherwise provided by this Contract, the payment method will be one or more of the following:

  • Payment for TIPS Sales TIPS Members may make payments for TIPS Sales directly to Vendor, Vendor’s Authorized Reseller, or as otherwise agreed to in the applicable Supplemental Agreement after receipt of the invoice and in compliance with applicable payment statutes. Regardless of how payment is issued or received for a TIPS Sale, Vendor is responsible for all reporting and TIPS Administration Fee payment requirements as stated herein.